VivoSim Labs, Inc. Warrants and Rights Outstanding
VivoSim Labs, Inc. (VIVS) had Warrants and Rights Outstanding of $4.30 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-08-12
- 2026-06-30: Warrants and Rights Outstanding $4.30M.
- 2013-12-31: Warrants and Rights Outstanding $1.00M.
- 2013-09-30: Warrants and Rights Outstanding $800.00K.
- 2013-03-31: Warrants and Rights Outstanding $6.90M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2026-06-30 | $4.30M 10-Q · filed 2026-08-12 |
| 2013-12-31 | $1.00M 10-Q · filed 2014-02-06 |
| 2013-09-30 | $800.00K 10-Q · filed 2013-11-08 |
| 2013-03-31 | $6.90M 10-Q · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |